SPECT/CT与PET/CT时代的前哨淋巴结显像与放射性引导手术:迈向新型介入核医学策略
本文综述前哨淋巴结(SN)显像与放射性引导手术的技术进展和新增临床适应证,检索PubMed相关文献分析当前方法与趋势。黑色素瘤和乳腺癌等经典适应证中,高危患者结合术前与术中新技术成为新兴临床方向;PET/CT与SN流程序贯使用在腋窝和骨盆等高危区域管理中日增;介入核医学技术对局部区域转移和寡转移性疾病正成为有价值的选择。
要点
- 黑色素瘤和乳腺癌等高危患者中,结合现有与新型术前和术中技术的SN方法正成为新兴临床适应证。
- 淋巴引流复杂的其他恶性肿瘤SN活检分期中,引入精细工具最有帮助。
- PET/CT与SN流程序贯使用作为特定区域(如腋窝和骨盆)高危患者的潜在联合管理方式正在增加。
核心结论
- SN活检的广泛经验正推动技术进步,使该流程可用于其他淋巴引流复杂的恶性肿瘤分期。
- 结合SPECT/CT与PET/CT引导SN和隐匿转移灶切除的新型核医学方法近期日益受到重视。
- 对局部区域转移和寡转移性疾病的管理,介入核医学技术正成为有价值的选择。
研究设计与样本
- 综述类:在PubMed进行文献检索,选取相关文章作为关键参考文献,分析SN与放射性引导手术的当前方法与趋势及核医学介入技术在各临床应用中的演变作用。
主要发现
- 黑色素瘤和乳腺癌等经典适应证中,基于现有与新型术前和术中技术联合的SN方法在高危患者类别中的整合正成为新兴临床适应证领域。
- 淋巴引流更复杂的其他恶性肿瘤SN活检分期中,引入精细工具最有帮助。
- PET/CT与SN流程的序贯使用正在增加,作为特定区域(如腋窝和骨盆)高区域播散风险患者的潜在联合管理方式。
- 对局部区域转移和寡转移性疾病的管理,介入核医学技术正成为有价值的替代选择。
- 结合SPECT/CT和PET/CT引导SN和隐匿转移灶切除的新型核医学方法近期日益受到重视。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We review recent technological advances and new clinical indications for sentinel node (SN) and radioguided surgery in order to delineate future tendencies of interventional nuclear medicine in this field. A literature research was performed in PubMed to select relevant articles to be used as key references for analysis of the current approaches and tendencies in SN and radioguided surgery, as well as the evolving contribution of nuclear medicine intervention techniques to the various clinical applications. For classic indications such as melanoma and breast cancer, the incorporation of the SN approach based on the combined use of existing and new preoperative and intraoperative technologies in high-risk patient categories is becoming an emerging area of clinical indication. For SN biopsy staging in other malignancies with more complex lymphatic drainage, the incorporation of sophisticated tools is most helpful. The consecutive use of PET/CT and the SN procedure is increasing as a potential combined approach for the management of specific areas such as the axilla and the pelvis in patients at high risk of regional dissemination. Also, for the management of locoregional metastasis and oligometastatic disease, interventional nuclear medicine techniques are becoming valuable alternatives. The extended experience with SN biopsy is leading to technological advances facilitating the incorporation of this procedure to stage other malignancies with complex lymphatic drainage. New nuclear medicine-based approaches, incorporating SPECT/CT and PET/CT to guide resection of SNs and occult metastases, have recently been gaining ground.
引用
- Valdés Olmos RA, Rietbergen DDD, Rubello D, et al. Sentinel Node Imaging and Radioguided Surgery in the Era of SPECT/CT and PET/CT: Toward New Interventional Nuclear Medicine Strategies. Clin Nucl Med. 2020. PMID: 32701805. doi:10.1097/RLU.0000000000003206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。